Lung cancer is a big problem. It claims many lives each year. Around 160,000 people die annually in the US. This figure is ...

Data from the DeLLphi-304 trial “clearly support tarlatamab as a preferable therapy” for SCLC in the second-line setting, said Charles M. Rudin, MD, PhD.

Cambridge: AstraZeneca has announced that Datroway (datopotamab deruxtecan or Dato-DXd) has received accelerated approval ...

Datroway received accelerated FDA approval for adults with EGFR+ advanced non-small cell lung cancer after EGFR-targeted and ...

AstraZeneca and Daiichi Sankyo's TROP2-directed antibody-drug conjugate (ADC) Datroway has been granted accelerated approval ...

FDA grants accelerated approval to AstraZeneca's Datroway for EGFR-mutant NSCLC after prior therapies, with a 45% response ...

Small cell lung cancer is aggressive and spreads quickly. There are many options for treatment, depending on the type and stage of SCLC.

Lurbinectedin plus atezolizumab significantly reduced the risk of disease progression or death by 46% compared with atezolizumab alone.

FirstHealth of the Carolinas will offer free lung cancer screenings using its mobile Lung Bus at FirstHealth Lee Campus located at 2919 Beechtree Drive in Sanford from 8:30 a.m. to 12:30 p.m. on ...

Patients with brain metastases from gastrointestinal cancers show worse survival after stereotactic radiosurgery than those ...